Dr. Zulekha Hamid, MD (she/her) is an Endocrinologist in Little rock, AR with over 16 years of experience. What is your opinion of Dr. Zulekha Hamid, MD? Rate this provider below so other people can make informed decision.
Over 16 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Zulekha Hamid, MD has received over $8,507 which includes payments from the following companies:
$1,411.35 from Amgen Inc.
$1,213.10 from Tandem Diabetes Care, Inc.
$1,144.84 from sanofi-aventis U.S. LLC
$892.43 from Novo Nordisk Inc
$782.19 from AstraZeneca Pharmaceuticals LP
$606.29 from Janssen Pharmaceuticals, Inc
$301.15 from AbbVie, Inc.
$270.92 from LILLY USA, LLC
$267.41 from Regeneron Pharmaceuticals, Inc.
$239.83 from Boehringer Ingelheim Pharmaceuticals, Inc.
$183.10 from Shire North American Group Inc
$153.98 from Takeda Pharmaceuticals America, Inc.
$107.36 from Eisai Inc.
$104.55 from Abbott Laboratories
$102.95 from AKRIMAX PHARMACEUTICALS, LLC
$98.45 from GENZYME CORPORATION
$97.68 from Radius Health, Inc.
$88.15 from Corcept Therapeutics
$86.68 from Valeritas, Inc.
$77.86 from Medtronic MiniMed, Inc.
Payments received by Dr. Zulekha Hamid, MD were from the following categories:
$7,090.87 Food and Beverage
$1,200.00 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!